Русский
Epidemiology of pertussis in the Yaroslavl Region during planned mass immunization
Druzhinina T.A., Shoshin A.A., Cheprasova E.V., Popova O.V.
1Yaroslavl State Medical University, Ministry of Health of Russia, Yaroslavl, Russia; 2Directorate for the Yaroslavl Region, Russian Federal Service for Supervision of Consumer Rights Protection and Human Welfare, Yaroslavl, Russia
Materials and methods. The authors performed a comparative retrospective epidemiological analysis of the incidence of pertussis, the demographic situation, and the quality of vaccination in the Yaroslavl Region, by using data from the state infectious diseases reports by the Directorate for the Yaroslavl Region, Russian Federal Service for Supervision of Consumer Rights Protection and Human Welfare, and those by the Russian Federal Service for Supervision of Consumer Rights Protection and Human Welfare, statistical observation forms No. 2 «Information on Infectious and Parasitic Diseases» and No. 6 «Information on Contingents of Children and Adults Vaccinated Against Infectious Disease» over 2004–2016.
Results. Whatever the coverage and timeliness of immunization, whooping cough was shown to be characterized by common epidemiological patterns: long-term dynamics, periodic upsurges of morbidity rates, changes in the structure of morbidity, and pronounced territorial irregularity. It was established that the intensity of the epidemic process of pertussis and the features of its manifestations were largely determined by the demographic situation, the size of the pediatric population, social conditions, and the insufficient duration of postvaccination immunity. Thus, in 2016, the incidence of pertussis increased by 8.7% compared to 2015, amounting to 23.1 per 100,000 population, which was 4.1 times the average level in the Russian Federation (5.6 per 100,000 population). The highest morbidity rates were noted among infants under 1 year of age (206.5 per 100,000 babies of this age) and schoolchildren (167.8 per 100,000 children in this category).
Conclusion. The features of the present-day epidemiology and clinical course of pertussis necessitate changing the vaccination tactics and introducing revaccination with acellular vaccines in children and adults. In order to protect newborns from whooping cough, it is advisable to promptly vaccinate all family members without a history of this infection, including adults. This will be able to protect a baby in the first 6 months of life before he/she develops postvaccination immunity.
Literature
1. Briko N.I., Mindlina A.Ya., Polibin R.V. [Universality of changes in epidemic process manifestations of anthroponosis infections in recent decades]. Zhurnal Microbiologii, Epidemiologii i Immunologii 2015; (5): 12–20. (In Russ.). 2. Fedoseenko V.M., Galitskaya M.G., Ivanova M.I., Gayvoronskiy A.G., Mayanskiy N.A., Botvin'yeva V.V., Rodionova T.V. [Is pertussis coming back? Improving control of a forgotten childhood infection]. Pediatricheskaya Farmacologiya 2012; (2): 28–36. (In Russ.). DOI: http://dx.doi.org/10.15690/ pf.v9i2.242 3. [Infectious morbidity in the Russian Federation in January–December 2016]. http://www.rospotrebnadzor.ru/activities/statistical-materials/tatictic_ details. php? ELEMENT_ID=7804. 4. Lapiy F.I. [Pertussis in infants: potential ways of preventing]. Sovremennaya Pediatriya 2012; (6): 35–8. (In Russ.). 5. Nadraga A. B., Dybas I. V. [Clinical and epidemiological features of the course of pertussis in children of the first year of life]. Zdorove rebenka 2013; (3): 131–5. (In Russ.). 6. Zajcev E.M., Mazurova I.K., Krasnoproshina L.I., Astahova T.I., Zaharova N.S. [Humoral immunity against pertussis and its prevalence in population]. Zhurnal Microbiologii, Epidemiologii i Immunologii 2009; (1): 56–8. (In Russ.). 7. Babachenko I.V. [Pertussis in children]. St.-Peterburg: Kommentariy Publ, 2014; 157–8. (In Russ.). 8. 2015 Final Pertussis Surveillance Report. http://www.cdc.gov/pertussis/ downloads/pertuss-surv-report-2015.pdf 9. Health Protection Report. Laboratory confirmed cases of pertussis to the enhanced pertussis surveillance programme in England: annual report for 2015. https://www.gov.uk/government/ uploads/system/uploads/attachment.data/file/521637/ hpr1616_prtsss_ann.pdf. 10. Tatochenko V.K. [Pertussis – Infection not under Complete Control]. Voprosy Sovremennoi Pediatrii. 2014; 13 (2): 78–8. (In Russ.). 11. Ward J.I., Cherry J.D., Chang S.J. Bordetella pertussis in vaccinated and unvaccinated adolescents and adults, as assessed in a National Prospective Randomized Acellular Pertussis Vaccine Trial (APERT). Clin. Infect. Dis. 2006; (4): 151–7 12. Jozefovich O.V., Harit S.M., Kaplina S.P., Gostev V.V., Sidorenko S.V., Kalinogorodskaya O.S., Kvetnaya A.S., Timofeeva E.V., Okuneva M.V. [The prevalence of pertussis among chronically coughing 6–17 years old children, vaccinated at an early age with DTP vaccine]. Epidemiologiya i Vakcinoprofilaktika 2012; (5): 56–9. (In Russ.). 13. Skoff T.H., Kenyon C., Cocoros N., Liko J., Miller L., Kudish K., Baumbach J., Zansky S., Faulkner A., Martin S.W. Sources of infant pertussis infection in the United States. Pediatrics 2015; 136(4): 635–41. 14. Wendelboe A.M., Van Rie A., Salmaso S., Englund J.A. Duration of immunity against pertussis after natural infection or vaccination. Pediatr. Infect. Dis. J. 2005; 24(5 Suppl): S58–S61.
About the Autors
For correspondence: Tat’yana A. Druzhinina: е-mail: druzhininata@gmail.com
Similar Articles
